Terms: = Kidney tumors AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
5 results:
1. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract] [Full Text] [Related]
2. Management of Metastatic Renal Cell Carcinoma with Variant Histologies.
Flippot R; Damarla V; McGregor BA
Urol Clin North Am; 2020 Aug; 47(3):319-327. PubMed ID: 32600534
[TBL] [Abstract] [Full Text] [Related]
3. Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
Malouf GG; Flippot R; Dong Y; Dinatale RG; Chen YB; Su X; Compérat E; Rouprêt M; Mano R; Blum KA; Yao H; Mouawad R; Spano JP; Khayat D; Karam JA; Ho TH; Tickoo SK; Russo P; Hsieh JJ; Tannir NM; Hakimi AA
Sci Rep; 2020 Jan; 10(1):701. PubMed ID: 31959902
[TBL] [Abstract] [Full Text] [Related]
4. Mutations in renal cell carcinoma.
D'Avella C; Abbosh P; Pal SK; Geynisman DM
Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
[TBL] [Abstract] [Full Text] [Related]
5. COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas.
Nie XC; Wang JP; Zhu W; Xu XY; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Hum Pathol; 2013 Jan; 44(1):77-86. PubMed ID: 22939955
[TBL] [Abstract] [Full Text] [Related]
